Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

8 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
HUNCHEST-II contributes to a shift to earlier-stage lung cancer detection: final results of a nationwide screening program.
Kerpel-Fronius A, Megyesfalvi Z, Markóczy Z, Solymosi D, Csányi P, Tisza J, Kecskés A, Baranyi B, Csánky E, Dóka A, Gálffy G, Göcző K, Győry C, Horváth Z, Juhász T, Kállai Á, Kincses ZT, Király Z, Király-Incze E, Kostyál L, Kovács A, Kovács A, Kuczkó É, Makra Z, Maurovich Horvát P, Merth G, Moldoványi I, Müller V, Pápai-Székely Z, Papp D, Polgár C, Rózsa P, Sárosi V, Szalai Z, Székely A, Szuhács M, Tárnoki D, Tavaszi G, Turóczi-Kirizs R, Tóth L, Urbán L, Vaskó A, Vigh É, Dome B, Bogos K. Kerpel-Fronius A, et al. Among authors: markoczy z. Eur Radiol. 2023 Nov 3. doi: 10.1007/s00330-023-10379-8. Online ahead of print. Eur Radiol. 2023. PMID: 37921926
Nationwide lung cancer screening with low-dose computed tomography: implementation and first results of the HUNCHEST screening program.
Kerpel-Fronius A, Monostori Z, Kovacs G, Ostoros G, Horvath I, Solymosi D, Pipek O, Szatmari F, Kovacs A, Markoczy Z, Rojko L, Renyi-Vamos F, Hoetzenecker K, Bogos K, Megyesfalvi Z, Dome B. Kerpel-Fronius A, et al. Among authors: markoczy z. Eur Radiol. 2022 Jul;32(7):4457-4467. doi: 10.1007/s00330-022-08589-7. Epub 2022 Mar 5. Eur Radiol. 2022. PMID: 35247089
Erlotinib as single agent first line treatment in locally advanced or metastatic activating EGFR mutation-positive lung adenocarcinoma (CEETAC): an open-label, non-randomized, multicenter, phase IV clinical trial.
Markóczy Z, Sárosi V, Kudaba I, Gálffy G, Turay ÜY, Demirkazik A, Purkalne G, Somfay A, Pápai-Székely Z, Rásó E, Ostoros G. Markóczy Z, et al. BMC Cancer. 2018 May 25;18(1):598. doi: 10.1186/s12885-018-4283-z. BMC Cancer. 2018. PMID: 29801465 Free PMC article. Clinical Trial.
Chromosomal Aberrations in Blood Lymphocytes as Predictors of Respiratory Function After Stereotactic Lung Irradiation.
Kocsis ZS, Farkas G, Bajcsay A, Kun-Gazda M, Lövey J, Ostoros G, Pócza T, Herein A, Ladányi K, Székely G, Markóczy Z, Takácsi-Nagy Z, Polgár C, Juranyi Z. Kocsis ZS, et al. Among authors: markoczy z. Front Oncol. 2022 Jan 27;11:829972. doi: 10.3389/fonc.2021.829972. eCollection 2021. Front Oncol. 2022. PMID: 35155217 Free PMC article.
A pleura óriás fibrosus tumora légzési elégtelenséggel szövődve.
Kas J, Csekeő A, Molnár M, Vágvölgyi A, Markóczy Z, Szabó E, Héjja M, Pénzes I, Rozgonyi Z, Soltész I, Fillinger J, Vadász P. Kas J, et al. Among authors: markoczy z. Magy Seb. 2015 Jun;68(3):94-8. doi: 10.1556/1046.68.2015.3.3. Magy Seb. 2015. PMID: 26084834 Hungarian.